ArticleCancer letters2015

Defective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: overcoming transport defects using a nanoparticle approach.

Sau Wai Hung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.